Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRS
4426
DELISTED
Antares Pharma, Inc.
ATRS
| $409K | ﹤0.01% |
124,271
+17,137
| +16% | +$49.6K |
|
|
AXNX
4427
DELISTED
Axonics, Inc. Common Stock
AXNX
| $408K | ﹤0.01% |
9,959
-10,720
| -52% | -$301K |
|
|
AHT
4428
Ashford Hospitality Trust
AHT
$21M
| $407K | ﹤0.01% |
139
-8
| -5% | -$37.5K |
|
4429
CALL
AES
AES
$10.5B
| $406K | ﹤0.01% |
24,200
-131,600
| -84% | -$2.23M |
|
4430
Horizon Bancorp
HBNC
$1.05B
| $406K | ﹤0.01% |
24,853
+13,517
| +119% | +$219K |
|
4431
Rhythm Pharmaceuticals
RYTM
$7.72B
| $406K | ﹤0.01% |
18,487
-1,036
| -5% | -$26.2K |
|
|
DPLO
4432
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $406K | ﹤0.01% |
66,700
+28,590
| +75% | +$152K |
|
|
CTLP
4433
DELISTED
Cantaloupe
CTLP
| $404K | ﹤0.01% |
54,333
+37,583
| +224% | +$233K |
|
|
LDL
4434
DELISTED
Lydall, Inc.
LDL
| $404K | ﹤0.01% |
20,010
+4,018
| +25% | +$87.5K |
|
|
CEPU
4435
Central Puerto
CEPU
$2.07B
| $403K | ﹤0.01% |
43,500
+12,742
| +41% | +$107K |
|
|
GLUU
4436
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $403K | ﹤0.01% |
56,100
-8,500
| -13% | -$78.1K |
|
4437
Bank of Marin Bancorp
BMRC
$465M
| $402K | ﹤0.01% |
9,799
+5,634
| +135% | +$237K |
|
4438
FB Financial Corp
FBK
$3.04B
| $402K | ﹤0.01% |
10,972
+6,348
| +137% | +$224K |
|
4439
Arcus Biosciences
RCUS
$3.61B
| $402K | ﹤0.01% |
50,605
+40,134
| +383% | +$402K |
|
|
MOBL
4440
DELISTED
MobileIron, Inc.
MOBL
| $402K | ﹤0.01% |
64,943
+43,906
| +209% | +$249K |
|
|
4441
PUT
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $401K | ﹤0.01% |
12,400
-1,496,700
| -99% | -$49.3M |
|
4442
Metropolitan Bank Holding Corp
MCB
$1.15B
| $401K | ﹤0.01% |
9,114
+6,991
| +329% | +$278K |
|
4443
PUT
Range Resources
RRC
$9.01B
| $401K | ﹤0.01% |
57,500
-19,500
| -25% | -$169K |
|
|
CZZ
4444
DELISTED
Cosan Limited
CZZ
| $401K | ﹤0.01% |
30,046
-87,703
| -74% | -$1.08M |
|
|
ESV
4445
CALL
DELISTED
Ensco Rowan plc
ESV
| $401K | ﹤0.01% |
46,975
+33,575
| +251% | +$388K |
|
4446
Ecovyst
ECVT
$1.2B
| $399K | ﹤0.01% |
25,207
+1,926
| +8% | +$30.3K |
|
|
FFIC
4447
DELISTED
Flushing Financial
FFIC
| $399K | ﹤0.01% |
17,988
+9,743
| +118% | +$215K |
|
4448
PUT
Patterson-UTI
PTEN
$3.83B
| $399K | ﹤0.01% |
34,700
+22,400
| +182% | +$288K |
|
|
NPTN
4449
DELISTED
NEOPHOTONICS CORP
NPTN
| $399K | ﹤0.01% |
95,526
-53,643
| -36% | -$283K |
|
|
HCR
4450
CALL
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $399K | ﹤0.01% |
162,000
+15,100
| +10% | +$47.2K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.